TCL Archive “Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor November 8, 2013
TCL Archive Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study January 28, 2011
TCL Archive In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC May 19, 2000
TCL Archive ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market January 24, 2003